Skip to main content

Relias Media has upgraded our site!

Please bear with us as we work through some issues in order to provide you with a better experience.

Thank you for your patience.

All Access Subscription

Get unlimited access to our full publication and article library.

Get Access Now

Interested in Group Sales? Learn more

In a randomized, clinical trial, patients with primary or recurrent basal-cell carcinoma were treated either by traditional surgical excision or Mohs’ micrographic surgery. At 30 months of follow-up, recurrence rates were low in both groups. For those with recurrent disease, there was a suggestion that the Mohs technique might be superior with regard to later recurrence.

MOHS vs Standard Surgical Excision for Facial Basal Cell Carcinoma